stars 1 stars 2 stars 3

BioSpectra Inc. (BSI), is a privately-owned manufacturer of premium pharmaceutical ingredients and bulk, cGMP fine chemicals, in service to many leading BioPharma companies around the world. We offer innovative purification and synthetic capabilities to produce finished cGMP products, that serve to enhance every stage of the drug manufacturing process – upstream, midstream and downstream. As a leader in cGMP manufacturing, our portfolio includes bulk GMP biological buffers, GMP Buffer Solutions, GMP process fine-chemicals, as well as new chemical entities (NCEs) produced at IPEC & ICH Q7 regulatory compliance levels. We specialize in small molecule synthesis and true, phase-change multi-step purification, providing solutions for various cGMP key ingredient issues at various stages of the drug manufacturing process.

BioSpectra, Inc. Questions

The BioSpectra, Inc. annual revenue was $8 million in 2026.

Richard Mutchler is the CEO of The BioSpectra Organization of BioSpectra, Inc..

109 people are employed at BioSpectra, Inc..

BioSpectra, Inc. is based in Bangor, Pennsylvania.

Top BioSpectra, Inc. Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users